Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stanford V versus ABVD for advanced Hodgkin's disease
ISRCTN64141244Phase 2Completed
- Sponsor
- British National Lymphoma Investigation
- Start
- Jan 2001
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of mechlorethamine, doxorubicin, vinblastine, prednisolone, vincristine and 3 more in Hodgkin lymphoma (HL) (2 arms), sponsored by British National Lymphoma Investigation. Primary endpoint: Primary endpoint not provided. Started Jan 2001; status: completed.
02
Drugs
mechlorethaminedoxorubicinvinblastineprednisolonevincristine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on ISRCTN64141244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64141244.